Biden Administration Backs Vaccine Intellectual Property Waiver
Biden Administration Backs Vaccine Intellectual Property Waiver
The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.
Biden Administration Backs Vaccine Intellectual Property Waiver
Biden Administration Backs Vaccine Intellectual Property Waiver

The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.

The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.

patent
Opinion: Stop Private Speculation in COVID-19 Research
Opinion: Stop Private Speculation in COVID-19 Research
Emiliano Brancaccio, Ugo Pagano | Mar 23, 2020
We present an economic plan for a collective sharing of scientific knowledge on the pandemic.
Opinion: Taxpayers Should Cover Portion of Patent Costs
Opinion: Taxpayers Should Cover Portion of Patent Costs
Paul R. Sanberg | Oct 9, 2019
Federal grant support for technology transfer at universities will strengthen the national innovation system.
Questions Surround Canadian Shipment of Deadly Viruses to China
Questions Surround Canadian Shipment of Deadly Viruses to China
Nicoletta Lanese | Aug 9, 2019
The same Winnipeg lab that sent Ebola and Henipah viruses to Beijing recently removed a number of researchers for an “administrative issue.”
A Brief Guide to the Current CRISPR Landscape
A Brief Guide to the Current CRISPR Landscape
Diana Kwon | Jul 15, 2019
Hundreds of CRISPR patents have been granted around the world, and the number of applications continues to grow at a rapid pace.
USPTO Restarts CRISPR Patent Dispute Between Broad and UC
USPTO Restarts CRISPR Patent Dispute Between Broad and UC
Jef Akst | Jun 26, 2019
The US patent office declares an interference between the intellectual property held by the Broad Institute and several patent applications filed by the University of California—opposite its previous ruling.
UC Berkeley Team to Be Awarded CRISPR Patent
UC Berkeley Team to Be Awarded CRISPR Patent
Kerry Grens | Feb 11, 2019
The group had argued that a patent given to the Broad Institute overlapped with this one.
Federal Court Sides with Broad in CRISPR Patent Dispute
Federal Court Sides with Broad in CRISPR Patent Dispute
Jef Akst | Sep 10, 2018
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
Patent On Autism Genetic Test May Stifle Science
Patent On Autism Genetic Test May Stifle Science
Jessica Wright | May 30, 2018
LabCorp might be able to charge a licensing fee to any scientists who wish to sequence the gene HOMER1 in people who may have autism.
CRISPR Patent Dispute Heard in Federal Court
CRISPR Patent Dispute Heard in Federal Court
Jim Daley | May 1, 2018
In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.
Women Less Successful When Applying for Patents
Women Less Successful When Applying for Patents
Diana Kwon | Apr 18, 2018
An investigation of 2.7 million patent submissions in the U.S. finds gender disparities throughout the application process.
Berkeley CRISPR Inventors Get Another Important European Patent
Berkeley CRISPR Inventors Get Another Important European Patent
Jim Daley | Mar 12, 2018
This is the second patent the European Patent Office has issued to the institutions of Jennifer Doudna, Emmanuelle Charpentier, and colleagues.
How to Successfully Collaborate with Industry
How to Successfully Collaborate with Industry
Ashley P. Taylor | Mar 1, 2018
In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.
2017 in Quotes
2017 in Quotes
Catherine Offord | Dec 28, 2017
Gender discrimination, Brexit, and climate change are among the issues that have received considerable attention from the scientific community this year.
2017’s Science News in Review
2017’s Science News in Review
Kerry Grens | Dec 15, 2017
Hurricanes, protests, and lifesaving genetic engineering: our picks for the biggest stories of the year
Flux and Uncertainty in the CRISPR Patent Landscape
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
Nature Index Identifies Top Contributors to Innovation
Nature Index Identifies Top Contributors to Innovation
Catherine Offord | Aug 9, 2017
New rankings highlight institutions that have produced large numbers of articles cited in others' patents.
UC Berkeley: Patent Office “Ignored Key Evidence”
UC Berkeley: Patent Office “Ignored Key Evidence”
Jef Akst | Jul 26, 2017
The University of California files a brief in its appeal challenging the ruling that the Broad Institute’s group would retain its CRISPR genome-editing patent.
The Invention Return on NIH Investments
The Invention Return on NIH Investments
Kerry Grens | Apr 2, 2017
Around 8 percent of grants funded by the National Institutes of Health resulted in patents.